Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 Legality  




2 See also  




3 References  













PX-1







Add links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

PX-1
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
    • Identifiers

    • (S)-N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

    CAS Number
    PubChem CID
    ChemSpider
    UNII
    Chemical and physical data
    FormulaC23H26FN3O2
    Molar mass395.478 g·mol−1
    3D model (JSmol)

    • O=C(N[C@H](C(N)=O)CC1=CC=CC=C1)C2=CN(CCCCCF)C3=C2C=CC=C3

    • InChI=1S/C23H26FN3O2/c24-13-7-2-8-14-27-16-19(18-11-5-6-12-21(18)27)23(29)26-20(22(25)28)15-17-9-3-1-4-10-17/h1,3-6,9-12,16,20H,2,7-8,13-15H2,(H2,25,28)(H,26,29)/t20-/m0/s1

    • Key:DDVANTXQCRMRFF-FQEVSTJZSA-N

    PX-1 (also known as 5F-APP-PICA and SRF-30) is an indole-based synthetic cannabinoid that has been sold online as a designer drug.[1][2][3]

    Legality

    [edit]

    Sweden's public health agency suggested classifying PX-1 as hazardous substance on November 10, 2014.[4]

    PX-1 is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

    See also

    [edit]
  • 5F-ADB
  • 5F-AMB
  • 5F-APINACA
  • AB-FUBINACA
  • AB-CHFUPYCA
  • AB-CHMINACA
  • AB-PINACA
  • ADB-CHMINACA
  • ADB-FUBINACA
  • ADB-PINACA
  • ADBICA
  • APICA
  • APINACA
  • MDMB-CHMICA
  • PX-2
  • PX-3

    • References

    [edit]
    1. ^ "PX 1". Cayman Chemical. Retrieved 15 July 2015.
  • ^ Presley BC, Logan BK, Jansen-Varnum SA (March 2020). "Phase I metabolism of synthetic cannabinoid receptor agonist PX-1 (5F-APP-PICA) via incubation with human liver microsomes and UHPLC-HRMS". Biomedical Chromatography. 34 (3): e4786. doi:10.1002/bmc.4786. PMID 31863591. S2CID 209435138.
  • ^ Dahm P, Thomas A, Rothschild MA, Thevis M, Mercer-Chalmers-Bender K (July 2022). "Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models". Forensic Toxicology. 40 (2): 244–262. doi:10.1007/s11419-021-00606-6. PMC 9715525. PMID 36454402. S2CID 245540105.
  • ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" [Cannabinoids are proposed to be classified as dangerous to health] (in Swedish). Folkhälsomyndigheten. Retrieved 16 July 2015.
  • ^ "Misuse of Drugs Act". Singapore Government. 30 April 2015. Retrieved 24 July 2015.
    • Stub icon

    This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=PX-1&oldid=1157518701"
    Categories: 
    ●Indoles
     ●Cannabinoids
     ●Designer drugs
     ●Indolecarboxamides
     ●Organofluorides
     ●Cannabinoid stubs
     Hidden categories: 
    ●CS1 Swedish-language sources (sv)
     ●Articles with short description
     ●Short description matches Wikidata
     ●Articles without EBI source
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Drugs missing an ATC code
     ●Articles containing unverified chemical infoboxes
     ●All stub articles
      


    ●This page was last edited on 29 May 2023, at 05:16 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki